Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Crescent Energy enters the final three weeks before its November 3 earnings report with two contradictory signals: the dominant activist shareholder just raised its stake materially, while shorts trimmed modestly and the borrow market opened up sharply.
The most newsworthy development this week is on the activist register. KKR Upstream Associates filed a Schedule 13D/A on October 13, lifting its disclosed stake from 10.5% to 16.3% of the class, representing 68.7 million shares. That is a significant step up from an already large position. John C. Goff also sits on the 13D register at 3.8% of the class. Together, these two activist holders account for more than a fifth of the company on an as-last-disclosed basis. The standard caveat applies: 13D/G positions are event-driven disclosures around the 5% threshold, and a holder dropping below 5% may exit without filing again. But KKR's move in the opposite direction, adding to a position already well above that threshold, is the kind of signal that warrants attention. BlackRock separately reported 9.4% of shares as of September 30, adding nearly 3 million shares in the quarter.
The positioning picture has shifted since last week's note, though not dramatically. Short interest dipped 6% on October 13 to 34.6 million shares, pulling back from the 36.9 million that had built up over October 9 to 12. The position remains 13.6% of the free float and is still up roughly 21% over the past month, so the underlying trend from the prior note holds. What has changed is the borrow market. Availability jumped sharply to 1,302% from around 727% a week earlier, the loosest reading in the past 30 days and well above the 52-week trough of 225%. Cost to borrow is a negligible 0.44%. Shorts rebuilt through late September and held their position into early October; Tuesday's step-down may reflect some covering, but with availability this loose, there is nothing in the lending market pressuring them either way. The ORTEX short score eased to 54.5 from 57.3 a week ago, consistent with a slight softening in short-side conviction.
Options traders have nudged slightly more defensive. The put/call ratio is 0.42, just above the 20-day mean of 0.38 and roughly one standard deviation elevated. That is close to the 52-week high of 0.45 but not at it. The pattern from October's first two weeks, where the PCR jumped abruptly from a sub-0.35 September base, has stabilised rather than extended. Hedging demand is present but not intensifying.
The Street remains constructively positioned, though targets have been trimmed at the margin. Evercore ISI lowered its target to $17 from $18 this week while maintaining Outperform. UBS cut to $18 from $19 earlier in the week, also keeping Buy. Wells Fargo went the other way, raising to $20 from $19 with Overweight. The mean target is $18.00 against a close of $13.06, implying material upside in the analyst consensus. The bull case centres on free cash flow generation, low-decline production from the Texas and Rocky Mountain portfolio, and the company's focus on shareholder returns over production growth. Bears point to reliance on third-party development activity and midstream infrastructure, both outside the company's direct control. The forward earnings revision story is striking: the eps_12m_fwd_yoy_increase factor ranks in the 99th percentile of the universe. EV/EBITDA is 3.4x, and P/E is 5.5x, both compressed multiples that have drifted lower over the past 30 days.
On insider activity, the three September 23 Form 4 filings from the CEO, CFO and EVP Investments are all coded as transaction type "J," a non-market transfer rather than an open-market purchase, so they carry less directional signal than a discretionary buy would.
Peers recovered strongly this week. CHRD added 6.5%, PR gained 8.5%, APA rose 8.9% and COP climbed 8.9%. CRGY's 4.1% weekly decline stands in contrast to that group, underperforming across the E&P peer set despite Tuesday's 2.2% bounce. Whether that gap narrows or widens into November 3 is the question the KKR filing makes considerably more interesting.
See the live data behind this article on ORTEX.
Open CRGY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
